Defibrotide for use in prophylaxis and/or treatment of Graft versus Host Disease (GVHD)
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Mar 17, 2015
Issued Date -
N/A
app pub date -
Nov 12, 2010
filing date -
Nov 12, 2010
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Defibrotide for use in prophylaxis and/or treatment of Graft versus Host Disease (GVHD) in humans is disclosed, preferably in hematopoietic stem cell transplantation (HSCT), more preferably allogeneic hematopoietic stem cell transplantation. Graft versus Host Disease of the invention (GVHD) can be acute aGVHD and/or chronic cGVHD, preferably acute.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully